Researchers established an association between inflammation and specific genetic mutations in Parkinson's patients. The study highlights two biomarkers that could be used to assess Parkinson's disease state and progression. The results also suggest that targeting the immune system with anti-inflammatory medication holds the potential to influence the disease course, at least in a subset of patients.

More...